Anti-inflammatory effects |
Atractylenolide I | Freund’s complete adjuvant-induced air pouch mice model | Blood; fluid from air pouches; granuloma tissues | 5, 10, 20 mg/kg; i.p. | 11 days | ↓NO, TNF-α, IL-1β, IL-6, VEGF, PlGF | [42] |
Aortic ring cocultured with peritoneal macrophages (mouse model) | / | 1, 5, 10 μg/ml | 12 h | ↓NO, TNF-α, IL-1β, IL-6, VEGF, PlGF |
Atractylenolide I | LPS-treated inflammatory RAW264.7 cells | / | 20, 40, 60 μM | 24 h | ↓IL-6, IL-1β | [43] |
Supercritical CO2 fluid extracts of AMKatractylenolide I14-acetoxy-12-senecioyloxytetradeca-2E,8E,10E-trien-4,6-diyn-1-ol | Acetic acid-induced vascular permeability mouse mode | Pigment in the abdominal cavity | 125, 250, 500 mg/kg (extracts), p.o.;30, 100, 300 mg/kg; p.o. | 30 min | ↓increased vascular permeability | [44] |
Carrageenan-induced paw edema mouse model | Paw volume | 100, 200, 400 mg/kg; i.p. | 3 days | ↑inhibition of edema | |
Cotton-pellet granuloma mouse model | Granuloma tissues | 30, 100, 300 mg/kg; p.o. | 7 days | ↑the percentage of inhibition of inflammation |
Atractylenolide I | LPS-treated inflammatory RAW264.7 cells | / | 1-100 µM | 24 h | ↓IL-6, TNF-α, activity of nuclear NF-κB and phosphorylation of ERK1/2 and p38, MD-2, CD14, SR-A, TLR4, MyD88 | [45] |
Immunomodulatory effects |
Polysaccharide extracts of AMK | Immune responses to foot-and-mouth vaccine (FMDV) (mouse model) | Blood, spleen tissue | 0, 0.025, 0.05, 0.1, 0.25 g; oral | 7 weeks | ↑IgG titers, IgG subclasses, IFN-γ, IL-5 and splenocyte proliferation stimulated by concanavalin A, lipopolysaccharide, and FMDV | [48] |
Polysaccharide extracts of AMK | FMDV mouse model | Blood, intestinal mucosa | 0.05 g; oral | 1 week and 2 weeks | ↑total sIgA, TGF-β, IL-6, TNF-α, IgA+ cells, intestinal intraepithelial lymphocytes in duodenum | [50] |
Water extracts of AMK | FMDV mouse model | Serum, spleen tissue | 0, 0.0625, 0.125, 0.25, 0.5 g; oral | 7 weeks | ↑IgG titers, IgG subclasses, IL-5, IFN-γ | [51] |
Pure AMK polysaccharidesCrude AMK polysaccharides | Piglets | Blood, contents from ileum, cecum and colon | 0.3%; oral | 14 days | ↑peripheral blood lymphocyte transformation rates and mRNA abundances of interleukin-6, TNF-α, IFN-γ, and nuclear factor of activated T cells transcription factor | [52] |
AMK powder | Piglets | Blood, spleen tissue | 1 g/kg; oral | 30 days | ↑IgG, IgA, IL-1, IL-2 | [53] |
Polysaccharide extracts of AMK | Heat stress chicken model | Spleen tissue | 200 mg/kg; oral | 6 weeks | ↑IL-2, IFN-γ, CAT activity, T-AOC, -OH inhibition, activities of mitochondrial complexes I, II and V, Mg2+-ATPase, Na+-K+-ATPase, Ca2+-ATPase, Drp1, Mfn1, Mfn2, Mff, Opa1, Bcl-xl↓IL-1β, TNF-α, Cyt-c, p53, Bak, Bax | [54] |
Antitumor effects |
Ethanol extracts of AMK | Head and neck cancer KB cell line | / | 1, 2, 3, 4 mg/mL | 24 h | ↑Bax/Bcl-2, LC3II, ATG5↓PARP1, p-AKT/AKT, mTOR | [59] |
Methanol extracts of AMK | Human lymphoma Jurkat T cells, leukemia U937 and HL-60 cells | / | 75, 100, 125 µg/mL | 24 h | ↑apoptosis, ROS | [60] |
Atractylenolide I | Human K562 CML, U937 AML and Jurkat T leukemia cells | / | 3.13-100 µg/mL | 12-72 h | ↑apoptosis↓caspase-3, caspase-9, CD14, CD68 | [61] |
Polysaccharide extracts of AMK | Glioma C6 cells | / | 10, 50, 100, 250, 500, 1,000 g/mL | 24, 48, and 72 h | ↑PARP, caspase-3, caspase-9, cytosol↓mitochondria | [62] |
Atractylenolide II | MCF 10A cells | / | 1-1,000 μM | 24, 48, and 72 h | ↑Nrf2, GSH/GSSG ratio↓IL-6, IL-1β, MDA, 8-OHdG | [63] |
N-nitroso-N-methylurea-induced breast cancer rat model | Mammary glands | 100, 200 mg/kg; i.p. | 3, 5, 9 weeks | ↑GSH/GSSG ratio, Nrf2, Ho-1, Nqo1, p-JNK/JNK, p-Erk1/2/Erk1/2↓IL-6, TNF-α, 8-OHdG, MDA, TNF-α, IL-6 |
Regulator effects on energy metabolism |
Water extracts of AMK | 3T3-L1 cells | / | 1, 5, 10, 25 g/mL | 8 days | ↓adipogenesis, adipocyte differentiation, p-AKT/AKT | [64] |
High fat diet-fed rats | Plasma | 0.5 g/kg; oral | 6 weeks | ↓final body weight, triglyceride |
Water extracts of AMK | C2C12 cells | / | 0.2, 0.5, 1.0 mg/mL | 25 h | ↑PGC1α, NRF1, TFAM, total ATP, UCP3, p-AMK/AMK, p-ACC/ACC, SIRT1, GLUT-4, glucose uptake, CPT-1β↓FFA | [65] |
Water extracts of AMK | High fat diet-fed mice | Serum and liver, brown adipose tissue, pancreas, gastrocnemius muscle tissue | 100, 300 mg/kg | 16 weeks | ↑PGC1α, UCP1, p-AMPK/AMPK, HO-1, CAT, NRF1, TFAM↓body weight, fasting serum glucose, serum insulin levels, glucose intolerance, serum total cholesterol | [66] |
Regulatory effects on gastrointestinal function |
Polysaccharide extracts of AMK | Intestinal flora rat model | Feces | 0.035, 0.105 g/kg; oral | 10 days | ↑body weights, Shannon’s diversity index↓ecological balance of intestinal flora, flora species | [33] |
Methanol extracts of AMK | IEC-6 cell injury model | / | 50, 100, 200 µg/mL | 24 h | ↑polyamine content, membrane hyperpolarization, elevation of [Ca2+]cyt, acceleration of cell migration, Kv1.1 | [67] |
Ethanol extracts of AMK | IEC-6 cell injury model | / | 50, 100, 200 mg/L | 12 h | ↑cellular polyamine content, RhoA, nonmuscle myosin II, formation of nonmuscle myosin II stress fibers, acceleration of cell migration, Rac1 ↓CDC42 | [68] |
Water extracts of raw AMK, bran-roasted AMK and charred AMK | Alcohol-induced gastric ulcer mouse model | Stomach tissue | 1.5 g/kg; oral | 5 days | ↓Percentage of ulcer area, ulcer index | [69] |
Charred AMK nanocomponents | Alcohol-induced gastric ulcer mouse model | Blood, stomach tissue | 0.4, 1.3, 5.1 g/kg | 5 days | ↑IL-10, PGE2, MUC5AC↓Percentage of ulcer area, ulcer index, IL-6, MDA, H+, K+ ATPase, Pepsin, IL-1β, TNF-α |
Neuroprotective effects |
Ethanol extracts of AMK | Excitotoxicity induced by glutamate in cortical neurons | Cortical neurons | 120-240 µg/mL | 24 h | ↑cell viability↓apoptosis, DNA laddering | [73] |
Biatractylolide | PC12 and SH-SY5Y Cells | / | 10, 15, 20 μM | 24 h | ↑p-Akt↓GSK3 β, apoptosis, LDH release, ROS | [74] |
Atractylenolide III | Learning and memory impairment rat model | Hippocampus | 0.6, 1.2, 2.4 mg/kg; oral | 6 weeks | ↑p-PKC↓ROS, Casp-3 | [76] |
Atractylenolide III | Glutamate-induced neuronal apoptosis model | Cortical neurons | 10, 20, 40 μM | 24 h | ↓apoptosis, DNA laddering, Casp-3 | [77] |
Polysaccharide extracts of AMK | Neuronal apoptosis induced by hypoxia | Cortical neurons | 0.025, 0.05, 0.10, 0.25, 0.50, 1.0, 2.0, 4.0 g/L | 48 h | ↑Bcl-2, Bcl-2/Bax↓apoptosis, Casp-3, Bax | [78] |
Regulatory effects on sex hormones and anti-uterine contraction effects |
Ethanol extracts of AMK | Hyperandrogenic rat model of PCOS | Blood, uterus and ovaries | 0.1, 0.3, 0.9 g/kg; oral | 8 weeks | ↑follicle stimulating hormone, follicle stimulating hormone receptor, aquaporin-9↓total testosterone, free androgen index, androstenedione, luteinizing hormone/follicle stimulating hormone, antimüllerian hormone | [80] |
Soluble AMK extract (powder) | IL-6-stimulated human pregnant myometrial smooth muscle cell model | Human pregnant myometrial smooth muscle cells | 1, 2, 4 mg/mL | / | ↑BKca | [81] |
Ethanol extracts of AMK | Bilaterally ovariectomized rat model | Serum | 0.3 g/kg; oral | 8 weeks | ↑E2, osteocalcin↓FSH, IL-6 | [82] |
Antioxidant and antiaging effects |
Polysaccharide extracts of AMK | Ischemia‒reperfusion injury rat model | Liver | 0.4 g/kg; oral | 7 days | ↑↓ALT, AST, TBIL, DBIL, MDA, NF-κB, IL-1β | [83] |
Polysaccharide extracts of AMK | D-galactose-treated rat model | Blood, brain | 100, 200 mg/kg; oral | 6 weeks | ↑GSH-Px, CAT, T-AOC, SOD↓MDA, MAO, Lipo | [84] |
Antiosteoporotic effects |
Ethanol extracts of AMK | RANKL-induced bone loss mouse model | Bone marrow-derived macrophages | 10-200 µg/mL | 48 h | ↓c-Fos, NFATc1, p-ERK/ERK, p-JNK/JNK, p-P38/P38 | [85] |
RANKL-induced bone loss mouse model | Right femur | 0.25, 0.75 g/kg; oral | 5 days | ↓bone loss |
Atractylenolide I, atractylenolide Ⅲ | Mesenchymal stem cells | / | 1-300 µg/mL | 7 days | ↑collagen II, aggrecan, SOX9, Shh, Gli-1 | [86] |
Antibiotic effects |
Ethanol extracts of AMK | Staphylococcus aureus,Escherichia coli, Bacillus,subtilis, Shigella flexneri | / | 5-40 mg/mL | 24 h | ↑inhibited growth | [88] |
Water extracts of AMK | Staphylococcus aureus,Escherichia coli | / | | 24 h | ↑inhibited growth | [89] |